Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Explore how weekly and monthly automatic buys work for Dividend Aristocrats ETFs and why they can simplify investing. Learn practical steps to set up automatic contributions.
16,919 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Strong cloud demand and AI-driven spending helped lift amazon and alphabet today, putting the spotlight on the broade...
Silver has tumbled since January, trading around $60 as markets weigh a possible comeback driven by industrial demand...
NVIDIA outperformed the wider semiconductor complex last week as AI demand strengthens its growth trajectory, leading...
U.S. stocks climbed on Tuesday as inflation cooled more than expected, helping the S&P 500 regain ground. Futures poi...
Two space pioneers, two distinct paths to growth. This guide compares SpaceX Spacemobile and AST SpaceMobile, with pr...
Investors who rode Nvidia's AI surge may wonder if the stock remains a millionaire-maker. This guide weighs the facto...
A fresh wave of buying interest in XRP, Solana, and Shiba Inu hits the market as traders watch key resistance levels ...
Celebrity relocations spotlight a bigger trend: it’s more than george. U.S. households are weighing overseas options ...
A weekend strike campaign put the U.S. on center stage as China and Russia offered only verbal condemnations. Markets...
As March 2026 unfolds, traders face a crowded field of options beyond Trading 212. This report identifies the best tr...
Cannabis operators reported strong cash flow in 2025, but a federal tax rule still caps upside. Investors are watchin...